Anti-proprotein converting enzyme subtilisin kexin type 9 (anti-PCSK9) compound and methods of using it for the treatment and / or prevention of cardiovascular disease

摘要

Disclosed are compounds that modulate the physiological effects of the proprotein convertase subtilisin kexin type 9 (PCSK9) and therapeutic methods for use of the compounds to reduce LDL cholesterol levels and / or high A method of use for the treatment and / or prevention of cardiovascular disease (CVD), including the treatment of cholesterolemia.